posted June 03, 2022 05:29 am by Karylle
(0)
FSD Pharma ready to proceed with Phase 2 clinical trial of
...read more
posted April 18, 2022 02:40 am by Karylle
(0)
FSD Pharma is delighted to announce pre-clinical findings
...read more
posted April 09, 2022 12:55 pm by Karylle
(0)
FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A)
...read more
posted April 07, 2022 01:05 pm by Karylle
(0)
FSD Pharma Issues Corporate Updates TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to
...read more
posted June 18, 2021 07:54 am by AwareInvestor
(544)
Atai Life Sciences late last night announced the pricing of its upsized initial public offering. The clinical-stage biotech firm now expects its IPO to raise gross proceeds of roughly $225.0 million
...read more